Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

This education program offers expert guidance on alpha-1 antitrypsin deficiency (AATD)–associated liver disease (LD), aiming to enhance HCPs’ knowledge in diagnosing and assessing AATD-LD. It targets hepatologists, gastroenterologists, and pulmonologists, with a secondary focus on primary care providers, nurse practitioners, physician associates, and pediatricians managing patients with AATD.

Share

Program Content

Events

Activities

Screening for AATD-LD
Screening for Alpha-1 Antitrypsin Deficiency Liver Disease: Call to Action
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2024

Expires: August 27, 2025

FAQs for AATD-LD
Alpha-1 Antitrypsin Deficiency in Liver Disease: Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2024

Expires: December 09, 2025

Faculty

cover img faculity

Virginia Clark, MD, MS

Clinical Professor of Medicine
Division of Gastroenterology, Hepatology, & Nutrition
University of Florida College of Medicine
Gainesville, Florida

cover img faculity

Pavel Strnad, MD

Full Professor
Department of Internal Medicine III
University Hospital Aachen
Aachen, Germany

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Takeda Development Center Americas, Inc.

Takeda Development Center Americas, Inc.